Top performing ASX 200 healthcare shares in August

These ASX 200 healthcare shares topped the leaderboards in August.

| More on:
three excited doctors with hands in the air

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

August was a bumper month for ASX 200 healthcare shares with broad based buying across the sector.

The S&P/ASX 200 Health Care (INDEXASX: XHJ) index rallied 6.8% last month to an 18-month high and less than 3% away from all-time highs.

The solid performance was headlined by these top performing players.

Top performing ASX 200 healthcare shares in August

Nanosonics Ltd (ASX: NAN)

The Nanosonics share price rallied 23.5% in August to a 7-month high of $6.62.

Nanosonics delivered its FY21 results on Tuesday, 24 August when its share price surged 21.9% to $7.18.

The company delivered a relatively flat financial performance with revenues up 3% to $103.1 million while net profit after tax declined 15% to $8.6 million.

Encouragingly, management said the company experienced a "significant recovery" in the second half of FY21, with revenues bouncing 16.3% compared to 2H20 figures.

Management believes this momentum is likely to continue, expecting double-digit revenue growth figures in FY22.

Pro Medicus Limited (ASX: PME)

Pro Medicus is another ASX 200 healthcare share that surged after the release of its FY21 results.

The Pro Medicus share price rallied 15.6% to $65.35 on Wednesday, 18 August after the company reported a 19.5% increase in FY21 revenue to $67.9 million and a 33.7% lift in net profit after tax to $30.9 million.

Management hailed the year as "our biggest year in terms of both sales and implementations, laying the foundations for a further step-up in exam volumes in FY22".

Despite the strong rally on the day of its results announcement, its gains would fade to 8.78% for the month of August.

Sonic Healthcare Ltd (ASX: SHL)

The Sonic Healthcare share price rallied 8.45% in August.

In contrast to the other top performing ASX 200 healthcare shares, the Sonic Healthcare share price fell almost 3% on the day of its FY21 results.

At face value, the company delivered an upbeat financial performance with revenue up 28% to $8.8 billion and net profit surging 149% to $1.3 billion.

However, the company flagged that its growth has been enhanced by COVID-19 testing revenue from its ~60 laboratories around the world.

Sonic Healthcare reported that COVID-19 PCR volumes were lower in the second half of the year versus the first half. However, volumes have been increasing again with the spread of the Delta variant.

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Nanosonics Limited and Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited and Pro Medicus Ltd. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

drug capsule opening up to reveal dollar signs signifying rising asx share price
Healthcare Shares

3 ASX healthcare shares going gangbusters on Thursday

Investors are sending these ASX healthcare stocks soaring today. But why?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Is it time to cash in on Sigma shares?

Shares have extended after the Chemist Warehouse merger.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Healthcare Shares

Buy this ASX 200 share that is swimming in cash

Bell Potter sees potentially big returns on offer from this cashed-up stock.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Are CSL shares a buy after the biotech's FY25 forecasts?

Brokers continue to weigh in.

Read more »

Female pharmacist smiles with a digital tablet.
Healthcare Shares

Are Wesfarmers or Sigma shares a better buy in the pharmacy arena?

These two stocks are both leaders in the industry.

Read more »

A young man goes over his finances and investment portfolio at home.
Healthcare Shares

Down 20%, is the NIB share price undervalued?

Here's what Goldman Sachs is saying about this blue chip stock.

Read more »

four excited doctors with their hands in the air
Healthcare Shares

Sigma Healthcare shares rocket 39% on Chemist Warehouse merger approval

The ACCC doesn't believe the company's merger with Chemist Warehouse will lessen competition.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

ASX 200 healthcare stock rockets on $75 million news

This marks another positive step for the company.

Read more »